prochlorperazine has been researched along with Bilateral Headache in 27 studies
Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a single site, randomized, double-blind, placebo-controlled trial investigating the clinical efficacy of IV acetaminophen as an adjunct to a standard therapy with prochlorperazine and diphenhydramine for the treatment of patients who present to the ED with a chief complaint of "headache" or variants thereof." | 9.24 | Randomized Trial of Adding Parenteral Acetaminophen to Prochlorperazine and Diphenhydramine to Treat Headache in the Emergency Department. ( Hysell, MK; Meyering, SH; Stringer, RW, 2017) |
| "Previous uncontrolled, nonrandomized trials suggest that magnesium sulfate (MgSO(4)) is effective in the treatment of headache." | 9.09 | A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. ( Ginder, S; Oatman, B; Pollack, M, 2000) |
| "Droperidol was more effective than prochlorperazine in relieving pain associated with benign headaches." | 9.09 | Droperidol vs. prochlorperazine for benign headaches in the emergency department. ( Biros, MH; Fish, SJ; Miner, JR; Smith, SW, 2001) |
| "In a prospective, randomized, double-blind clinical trial, intravenous prochlorperazine edisylate (Compazine Edisylate) was compared with a placebo in the treatment of severe headaches." | 9.06 | Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. ( Dougherty, J; Jones, J; Sklar, D; White, W, 1989) |
| " Inclusion criteria was age ≥ 18 who presented to the emergency department with a chief complaint of headache who received either olanzapine, metoclopramide or prochlorperazine." | 8.31 | Comparison of efficacy and frequency of akathisia and dystonia between olanzapine, metoclopramide and prochlorperazine in ED headache patients. ( Brunette, ND; Chinn, E; Cole, JB; DeVries, P; Driver, BE; Klein, LR; Miner, JR; Mojica, E; Raiter, A; Stang, JL, 2023) |
| "Intravenous subdissociative-dose ketamine has been shown to be effective for pain management, but has not been specifically studied for headaches in the emergency department (ED)." | 7.88 | A Comparison of Headache Treatment in the Emergency Department: Prochlorperazine Versus Ketamine. ( Bartlett, A; Clark, JM; Forred, W; Gates, M; Patel, J; Pitotti, C; Rahbar, A; Sontgerath, JS; Zitek, T, 2018) |
| "To investigate the efficacy and long-term outcome of intravenous prochlorperazine for the treatment of refractory chronic daily headache." | 7.70 | Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. ( Fuh, JL; Juang, KD; Lu, SR; Wang, SJ, 2000) |
| "Prochlorperazine was superior to promethazine in the rate of headache reduction and rate of home drowsiness, with similar rates of akathesia, nausea resolution, patient satisfaction, and headache recurrence within 5 days of discharge." | 6.73 | Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial. ( Bachrach, EA; Callan, JE; Kostic, MA; Rieg, TS, 2008) |
| " Compared to other active drugs, it only showed a lower significant effect compared with granisetron regarding headache change while it showed significantly higher effects only with placebo in both rescue medication needs and headache-free symptoms and valproate in only rescue medication need." | 5.41 | The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. ( Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW, 2023) |
| "Headaches were aborted using four different intravenous regimens containing 0." | 5.28 | Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. ( Saadah, HA, 1992) |
| "We conducted a single site, randomized, double-blind, placebo-controlled trial investigating the clinical efficacy of IV acetaminophen as an adjunct to a standard therapy with prochlorperazine and diphenhydramine for the treatment of patients who present to the ED with a chief complaint of "headache" or variants thereof." | 5.24 | Randomized Trial of Adding Parenteral Acetaminophen to Prochlorperazine and Diphenhydramine to Treat Headache in the Emergency Department. ( Hysell, MK; Meyering, SH; Stringer, RW, 2017) |
| "Previous uncontrolled, nonrandomized trials suggest that magnesium sulfate (MgSO(4)) is effective in the treatment of headache." | 5.09 | A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. ( Ginder, S; Oatman, B; Pollack, M, 2000) |
| "The utility of intravenous prochlorperazine as an antiemetic agent and abortive therapy for headache may be limited by the frequent occurrence of akathisia, the distressing effects of which have been shown to disrupt patient care." | 5.09 | Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. ( Drotts, DL; Vinson, DR, 2001) |
| "Droperidol was more effective than prochlorperazine in relieving pain associated with benign headaches." | 5.09 | Droperidol vs. prochlorperazine for benign headaches in the emergency department. ( Biros, MH; Fish, SJ; Miner, JR; Smith, SW, 2001) |
| " Patients aged 18 years or older treated with prochlorperazine for headache, nausea, or vomiting were eligible for inclusion." | 5.09 | Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial. ( Brizendine, EJ; Chisholm, CD; Collins, RW; Cordell, WH; Giles, BK; Jones, JB; Walthall, JD, 2001) |
| "In a prospective, randomized, double-blind clinical trial, intravenous prochlorperazine edisylate (Compazine Edisylate) was compared with a placebo in the treatment of severe headaches." | 5.06 | Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. ( Dougherty, J; Jones, J; Sklar, D; White, W, 1989) |
| " For hemicrania we used cinnarizine, cyproheptadine, clonidine, histamine, pizotifene and reserpine; for cluster headache, cinnarizine, cyproheptadine, clonidine, histamine and reserpine; for tension headache, cyproheptadine; for psychogenic headache, allylpropylmalonylurea." | 5.04 | [Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1975) |
| " Inclusion criteria was age ≥ 18 who presented to the emergency department with a chief complaint of headache who received either olanzapine, metoclopramide or prochlorperazine." | 4.31 | Comparison of efficacy and frequency of akathisia and dystonia between olanzapine, metoclopramide and prochlorperazine in ED headache patients. ( Brunette, ND; Chinn, E; Cole, JB; DeVries, P; Driver, BE; Klein, LR; Miner, JR; Mojica, E; Raiter, A; Stang, JL, 2023) |
| "Intravenous subdissociative-dose ketamine has been shown to be effective for pain management, but has not been specifically studied for headaches in the emergency department (ED)." | 3.88 | A Comparison of Headache Treatment in the Emergency Department: Prochlorperazine Versus Ketamine. ( Bartlett, A; Clark, JM; Forred, W; Gates, M; Patel, J; Pitotti, C; Rahbar, A; Sontgerath, JS; Zitek, T, 2018) |
| " These studies had used a conventional Long instrument in the prospective assessment of 360 adult ED patients aged 17-65 years who received intravenous prochlorperazine (10 mg) in the treatment of headache or nausea and vomiting." | 3.73 | Development of a simplified instrument for the diagnosis and grading of akathisia in a cohort of patients receiving prochlorperazine. ( Vinson, DR, 2006) |
| "To investigate the efficacy and long-term outcome of intravenous prochlorperazine for the treatment of refractory chronic daily headache." | 3.70 | Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. ( Fuh, JL; Juang, KD; Lu, SR; Wang, SJ, 2000) |
| "Prochlorperazine was superior to promethazine in the rate of headache reduction and rate of home drowsiness, with similar rates of akathesia, nausea resolution, patient satisfaction, and headache recurrence within 5 days of discharge." | 2.73 | Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial. ( Bachrach, EA; Callan, JE; Kostic, MA; Rieg, TS, 2008) |
| "Headache was frequent in the control (69%), i." | 2.68 | The prophylactic antiemetic efficacy of prochlorperazine and ondansetron in nasal septal surgery: a randomized double-blind comparison. ( van den Berg, AA, 1996) |
| "Prochlorperazine injection has been upgraded to a highly recommended level because of the rich clinical experience for this treatment." | 1.72 | 2022 Taiwan Guidelines for Acute Treatment of Migraine. ( Lau, CI; Wang, YF, 2022) |
| "Cerebral venous thrombosis (CVT) is a rare, difficult-to-diagnose form of venous thromboembolic disease and is considered a type of stroke." | 1.51 | Cerebral Venous Thrombosis: An Uncommon Cause of Papilledema on Bedside Ocular Ultrasound. ( Arthur, J; Chadwick, S; Duran-Gehring, P; Kumetz, C; McIntosh, M, 2019) |
| "Headaches were aborted using four different intravenous regimens containing 0." | 1.28 | Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. ( Saadah, HA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (25.93) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Lau, CI | 1 |
| Wang, YF | 1 |
| Chinn, E | 1 |
| Brunette, ND | 1 |
| Driver, BE | 1 |
| Klein, LR | 1 |
| Stang, JL | 1 |
| DeVries, P | 1 |
| Mojica, E | 1 |
| Raiter, A | 1 |
| Miner, JR | 2 |
| Cole, JB | 1 |
| Abdelmonem, H | 1 |
| Abdelhay, HM | 1 |
| Abdelwadoud, GT | 1 |
| Alhosini, ANM | 1 |
| Ahmed, AE | 1 |
| Mohamed, SW | 1 |
| Al-Dardery, NM | 1 |
| Abd-ElGawad, M | 1 |
| Kamel, MA | 1 |
| Zitek, T | 2 |
| Sigal, T | 1 |
| Sun, G | 1 |
| Martin Manuel, C | 1 |
| Tran, K | 1 |
| Meyering, SH | 1 |
| Stringer, RW | 1 |
| Hysell, MK | 1 |
| Gates, M | 1 |
| Pitotti, C | 1 |
| Bartlett, A | 1 |
| Patel, J | 1 |
| Rahbar, A | 1 |
| Forred, W | 1 |
| Sontgerath, JS | 1 |
| Clark, JM | 1 |
| Arthur, J | 1 |
| Duran-Gehring, P | 1 |
| Kumetz, C | 1 |
| Chadwick, S | 1 |
| McIntosh, M | 1 |
| Callan, JE | 1 |
| Kostic, MA | 1 |
| Bachrach, EA | 1 |
| Rieg, TS | 1 |
| Vinson, DR | 3 |
| Hurtado, TR | 1 |
| Vandenberg, JT | 1 |
| Banwart, L | 1 |
| Weaver, CS | 1 |
| Jones, JB | 2 |
| Chisholm, CD | 2 |
| Foley, MJ | 1 |
| Giles, BK | 2 |
| Somerville, GG | 1 |
| Brizendine, EJ | 2 |
| Cordell, WH | 2 |
| Twigg, J | 1 |
| van den Berg, AA | 1 |
| Ginder, S | 1 |
| Oatman, B | 1 |
| Pollack, M | 1 |
| Lu, SR | 1 |
| Fuh, JL | 1 |
| Juang, KD | 1 |
| Wang, SJ | 1 |
| Drotts, DL | 1 |
| Morgenstern, LB | 1 |
| Huber, JC | 1 |
| Luna-Gonzales, H | 1 |
| Saldin, KR | 1 |
| Grotta, JC | 1 |
| Shaw, SG | 1 |
| Knudson, L | 1 |
| Frankowski, RF | 1 |
| Fish, SJ | 1 |
| Smith, SW | 1 |
| Biros, MH | 1 |
| Collins, RW | 1 |
| Walthall, JD | 1 |
| Nattero, G | 3 |
| Agostoni, A | 1 |
| Brandi, G | 1 |
| Cottino, A | 1 |
| Gai, V | 3 |
| Gastaldi, L | 3 |
| Lisino, F | 1 |
| Saadah, HA | 1 |
| Jones, J | 1 |
| Sklar, D | 1 |
| Dougherty, J | 1 |
| White, W | 1 |
| Clåirmont, AA | 1 |
| Turner, JS | 1 |
| Jackson, RT | 1 |
| Barrie, MA | 1 |
| Fox, WR | 1 |
| Weatherall, M | 1 |
| Wilkinson, MI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravenous Fluids in Benign Headaches Trail: A Randomized Single Blind Clinical Trial[NCT03185130] | Phase 4 | 58 participants (Actual) | Interventional | 2017-05-16 | Completed | ||
| The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine. A Multi-Center, Randomized, Double-Blind, Clinical Control Trial[NCT02735343] | Phase 3 | 5 participants (Actual) | Interventional | 2016-08-31 | Terminated (stopped due to only recruited 5 patients at this location) | ||
| The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.[NCT02657031] | Phase 4 | 54 participants (Actual) | Interventional | 2016-03-17 | Completed | ||
| A Randomized Double-blind Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache[NCT03472872] | Phase 4 | 500 participants (Actual) | Interventional | 2017-09-05 | Terminated (stopped due to no longer recruiting or studying) | ||
| Improving the Headache Management Care in the Emergency Unit by Using a Biological Marker: S100B Protein.[NCT03490500] | 63 participants (Actual) | Observational | 2018-10-24 | Completed | |||
| A Randomized Double Blinded Study Comparing Use of Prochlorperazine Versus Prochlorperazine and Ketorolac in the Treatment of Pediatric Migraine in the Emergency Department[NCT01534806] | Phase 4 | 0 participants (Actual) | Interventional | 2012-01-31 | Withdrawn (stopped due to Drug is backordered;) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Reduction in 100 mm Visual Analog Scale (VAS) Score. The maximum possible change in VAS score is 100 mm, representing the complete relief of maximum anxiety. A change of 0 mm corresponds to no change in anxiety level, and a negative value indicates worsening of the anxiety after the medication. (NCT02657031)
Timeframe: 0-60 minutes
| Intervention | mm (Mean) |
|---|---|
| Control Arm | 33.7 |
| Study Arm | 21.2 |
Reduction in 100 mm Visual Analog Scale (VAS) Score. Positive values represent a reduction in headache severity. The maximum possible change in VAS score is 100 mm, representing the complete relief of a maximally severe headache. A change of 0 mm corresponds to no change in headache severity, and a negative value indicates worsening of the headache after the medication. (NCT02657031)
Timeframe: 0-60 minutes
| Intervention | mm (Mean) |
|---|---|
| Control Arm | 63.5 |
| Study Arm | 43.5 |
Reduction in 100 mm Visual Analog Scale (VAS) Score. The maximum possible change in VAS score is 100 mm, representing the complete relief of maximum nausea. A change of 0 mm corresponds to no change in nausea level, and a negative value indicates worsening of the nausea after the medication. (NCT02657031)
Timeframe: 0-60 minutes
| Intervention | mm (Mean) |
|---|---|
| Control Arm | 38.9 |
| Study Arm | 22.9 |
Yes/No (NCT02657031)
Timeframe: 0-60 minutes
| Intervention | participants (Number) |
|---|---|
| Control Arm | 2 |
| Study Arm | 3 |
Yes/No (NCT02657031)
Timeframe: 0-60 minutes
| Intervention | participants (Number) |
|---|---|
| Control Arm | 3 |
| Study Arm | 3 |
1 review available for prochlorperazine and Bilateral Headache
| Article | Year |
|---|---|
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea | 2023 |
12 trials available for prochlorperazine and Bilateral Headache
| Article | Year |
|---|---|
I-FiBH trial: intravenous fluids in benign headaches-a randomised, single-blinded clinical trial.
Topics: Adolescent; Adult; Aged; Child; Diphenhydramine; Dopamine Antagonists; Female; Fluid Therapy; Headac | 2020 |
Randomized Trial of Adding Parenteral Acetaminophen to Prochlorperazine and Diphenhydramine to Treat Headache in the Emergency Department.
Topics: Acetaminophen; Administration, Intravenous; Adult; Analgesics; Diphenhydramine; Double-Blind Method; | 2017 |
Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial.
Topics: Adolescent; Adult; Dopamine Antagonists; Double-Blind Method; Emergency Service, Hospital; Female; H | 2008 |
Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial.
Topics: Adolescent; Adult; Dopamine Antagonists; Double-Blind Method; Emergency Service, Hospital; Female; H | 2008 |
Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial.
Topics: Adolescent; Adult; Dopamine Antagonists; Double-Blind Method; Emergency Service, Hospital; Female; H | 2008 |
Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial.
Topics: Adolescent; Adult; Dopamine Antagonists; Double-Blind Method; Emergency Service, Hospital; Female; H | 2008 |
Droperidol vs prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antiemetics; Dopamine Antagonists; | 2004 |
The prophylactic antiemetic efficacy of prochlorperazine and ondansetron in nasal septal surgery: a randomized double-blind comparison.
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Blood Pressure; Child; Double-Blind Method; Fem | 1996 |
A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches.
Topics: Adolescent; Adult; Analgesics; Chi-Square Distribution; Emergency Service, Hospital; Female; Headach | 2000 |
Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antiemetics; Conscious Sedation; Diphenhydramine; Double | 2001 |
Droperidol vs. prochlorperazine for benign headaches in the emergency department.
Topics: Adult; Analysis of Variance; Dopamine Antagonists; Droperidol; Emergency Service, Hospital; Female; | 2001 |
Droperidol vs. prochlorperazine for benign headaches in the emergency department.
Topics: Adult; Analysis of Variance; Dopamine Antagonists; Droperidol; Emergency Service, Hospital; Female; | 2001 |
Droperidol vs. prochlorperazine for benign headaches in the emergency department.
Topics: Adult; Analysis of Variance; Dopamine Antagonists; Droperidol; Emergency Service, Hospital; Female; | 2001 |
Droperidol vs. prochlorperazine for benign headaches in the emergency department.
Topics: Adult; Analysis of Variance; Dopamine Antagonists; Droperidol; Emergency Service, Hospital; Female; | 2001 |
Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Dose-Response Relationship, Drug; Double-Blind Met | 2001 |
[Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)].
Topics: Aspirin; Caffeine; Cinnarizine; Clinical Trials as Topic; Clonidine; Cyproheptadine; Drug Therapy, C | 1975 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Headache; Humans; Injections, Intravenous; Male; | 1989 |
Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives.
Topics: Adolescent; Adult; Aged; Aspirin; Clinical Trials as Topic; Ergonovine; Ergotamine; Female; Headache | 1968 |
14 other studies available for prochlorperazine and Bilateral Headache
| Article | Year |
|---|---|
2022 Taiwan Guidelines for Acute Treatment of Migraine.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Caffeine; Calcitonin G | 2022 |
Comparison of efficacy and frequency of akathisia and dystonia between olanzapine, metoclopramide and prochlorperazine in ED headache patients.
Topics: Cohort Studies; Double-Blind Method; Dystonia; Emergency Service, Hospital; Headache; Humans; Metocl | 2023 |
A Comparison of Headache Treatment in the Emergency Department: Prochlorperazine Versus Ketamine.
Topics: Adolescent; Adult; Aged; Anesthetics, Dissociative; Dopamine Antagonists; Dose-Response Relationship | 2018 |
Cerebral Venous Thrombosis: An Uncommon Cause of Papilledema on Bedside Ocular Ultrasound.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anesthetics, Local; Cerebral Veins; Computed Tomogra | 2019 |
Variations among emergency departments in the treatment of benign headache.
Topics: Adolescent; Adult; Aged; Algorithms; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Bino | 2003 |
Development of a simplified instrument for the diagnosis and grading of akathisia in a cohort of patients receiving prochlorperazine.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antiemetics; Dopamine Antagonists; Female; Headach | 2006 |
Unrecognized drug reaction.
Topics: Dysarthria; Headache; Humans; Prochlorperazine; Sialorrhea; Tachycardia | 1996 |
Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache.
Topics: Adult; Analgesics; Antipsychotic Agents; Female; Follow-Up Studies; Headache; Humans; Infusions, Int | 2000 |
Headache in the emergency department.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Diagnosis, Differential; Drug T | 2001 |
Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine.
Topics: Adolescent; Adult; Aged; Dihydroergotamine; Drug Therapy, Combination; Female; Headache; Humans; Inj | 1992 |
Intravenous prochlorperazine for acute headache.
Topics: Acute Disease; Emergencies; Headache; Humans; Infusions, Intravenous; Migraine Disorders; Prochlorpe | 1989 |
Dizziness: a logical approach to diagnosis and treatment.
Topics: Adult; Anemia; Audiometry; Carotid Artery Diseases; Dimenhydrinate; Female; Headache; Humans; Hypert | 1974 |
[Study of a test of active headache extinction].
Topics: Caffeine; Diagnosis, Differential; Headache; Humans; Indomethacin; Migraine Disorders; Prochlorperaz | 1968 |
[Changes in hemodynamics observed during the extinction phase of headache attacks].
Topics: Blood Pressure; Brachial Artery; Caffeine; Headache; Hemodynamics; Humans; Indomethacin; Migraine Di | 1968 |